Oklahoma SB 771 was introduced at the end of January and referred to the Senate Health and Human Services Committee. The bill would prohibit certain direct-to-consumer advertising by pharmaceutical companies. “Direct-to-consumer pharmaceutical advertising” includes “any promotional communication targeting consumers including, but not limited to television, radio, print media, digital platforms, social media, and print and […]
Read more
